Washington Trust’s Teladoc Health TDOC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-450
Closed -$11K 988
2022
Q3
$11K Buy
450
+300
+200% +$10.5K ﹤0.01% 636
2022
Q2
$5K Hold
150
﹤0.01% 726
2022
Q1
$11K Hold
150
﹤0.01% 664
2021
Q4
$14K Buy
+150
New +$17.9K ﹤0.01% 641
2021
Q2
Sell
-150
Closed -$27K 1080
2021
Q1
$27K Hold
150
﹤0.01% 627
2020
Q4
$30K Hold
150
﹤0.01% 598
2020
Q3
$33K Hold
150
﹤0.01% 523
2020
Q2
$28K Hold
150
﹤0.01% 499
2020
Q1
$23K Buy
+150
New +$17.5K ﹤0.01% 524

Other funds holding TDOC

Washington Trust's TDOC Position: Q4 2022 in Review

Washington Trust sold out of Teladoc Health (TDOC) in Q4 2022, closing a stake of 450 shares — an estimated $11K sold.

Washington Trust first reported a position in TDOC in Q1 2020 and held it in 9 quarters. The position peaked at $33K in Q3 2020. 443 funds tracked by Wall St. Rank hold TDOC as of Q4 2022.

  • Washington Trust reported no remaining Teladoc Health position as of Q4 2022 after selling out during the quarter.
  • Washington Trust sold 450 Teladoc Health shares in Q4 2022, an estimated $11K.
  • Washington Trust first reported a position in Teladoc Health in Q1 2020 and held it in 9 quarters.
  • Washington Trust's Teladoc Health position peaked at $33K in Q3 2020.
  • 443 funds tracked by Wall St. Rank held Teladoc Health as of Q4 2022.

Based on Washington Trust's 13F filing for Q4 2022, filed 8 Feb 2023.